This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page A41-A41, February 1, 2025. Introduction:Current guidelines do not support the use of stenting for severe symptomatic intracranial atherosclerotic disease (ICAD) over maximal medical therapy (MMT) as first line treatment. Periprocedural stroke was defined as <7d from stent placement.
Stroke: Vascular and Interventional Neurology, Ahead of Print. The aim of this study is to describe trends in the utilization of RICS in MT in the United States in the last decade.METHODSWe conducted a serial crosssectional study using all primary acute ischemic stroke (AIS) admissions with MT in the 20102020 National Inpatient Sample.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionDrug‐eluting stent (DES) use in symptomatic intracranial atherosclerosis disease (ICAD) has been described in the literature using different guiding and distal access catheters.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionVertebral artery stenting represents a viable option in treating symptomatic vertebral artery atherosclerotic stenosis. Those reporting patients with vertebral dissections were excluded. and 1.7%, respectively.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 3) Rescue stenting (RS) in these patients has shown promising rates of recanalization and better outcomes in preliminary studies. Therefore, rescue stenting can be considered as a safe and viable option in these patients.
Stroke, Ahead of Print. Asymptomatic high-grade carotid stenosis is an important therapeutic target for stroke prevention. Since then, transfemoral/transradial carotid stenting and transcarotid artery revascularization have emerged as alternatives to endarterectomy for revascularization.
Stroke, Volume 56, Issue 4 , Page e114-e118, April 1, 2025. Intracranial atherosclerotic stenosis is a leading cause of stroke with a significant risk of recurrent ischemic events despite aggressive medical management. However, 3 percutaneous angioplasty and stenting randomized trials showed negative or neutral results.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerosis‐related large vessel occlusion (ICAS‐LVO) is a common cause of failed mechanical thrombectomy (MT) in acute ischemic stroke (AIS) [1].
Stroke: Vascular and Interventional Neurology, Ahead of Print. Most respondents (86%) preferred acute treatment of ICAS‐LVO with rescue stenting (RS)±angioplasty. However, in patients who achieved recanalization with a severe fixed focal stenosis, most (58%) recommended primary medical management.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP64-ATMP64, February 1, 2024. Introduction:Short-term dual antiplatelet therapy (DAPT) lowers the risk of early stroke recurrence after mild non-cardioembolic ischemic stroke (NCIS) and high-risk transient ischemic attack. However, DAPT benefit in moderate-to-severe NCIS is unknown.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP9-AWMP9, February 1, 2024. Introduction:Intracranial atherosclerotic disease (ICAD) is a common cause of ischemic stroke worldwide. In the ICADLVO group, 23 out of 68 patients underwent angioplasty, whereas 38 patients received stenting.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionCarotid webs (CaW) have been increasingly recognized as a unique cause of recurrent ischemic strokes.1 of patients with acute ischemic stroke. The prevalence of CaWs has been reported to be between 1.2%
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionOcular ischemic syndrome (OIS) is a rare, vision‐threatening condition resulting from severe carotid artery disease secondary to severe atherosclerosis or arteritis. Carotid artery atherosclerosis is the most common etiology.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. There is subsequent hypoperfusion of brain tissue, but thromboembolism and ischemic stroke is rare. There is subsequent hypoperfusion of brain tissue, but thromboembolism and ischemic stroke is rare.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerosis (ICAS) is a leading global cause of stroke. The role of intracranial stenting in ICAS remains uncertain. 1‐year rate of stroke and death in stented patients [5].
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionMechanical thrombectomy (MT) is now the standard of care in treatment of large vessel occlusion (LVO) in acute ischemic stroke (AIS). A higher proportion of failure cases were due to large artery atherosclerosis (30.6%
A CT CAC scan can only identify if there is calcified atherosclerosis, where it is and to what extent. First off, CTCA is a noninvasive test, and many patients with chest pain would previously have needed invasive angiography with all the risks it entails, including heart attack, stroke and death (albeit very rare). And it matters.
Atherosclerosis & Arterial Diseases Peripheral Artery Disease (PAD) : A blockage in your legs. This can lead to a transient ischemic attack (TIA) or stroke. Carotid Ultrasound : Evaluates blood flow to the brain and detects stroke risk factors. Angioplasty & Stenting: Opens blocked arteries to improve blood flow.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content